Novartis stands by safety of eye drug amid ongoing review

Swiss drugmaker Novartis said on Monday the safety data available for its eye drug Beovu to treat wet age-related macular degeneration (wet AMD) continued to support its use as it conducts a review into the safety of the drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news